Wang-LysoLab (@WangLysolab) header
Wang-LysoLab (@WangLysolab) profile picture

Twitter Account for Ray Wang’s Translational Lysosomal Research Lab. Habitually too many projects, not enough publications. All thoughts and opinions are my own

CHOC
Joined June 2023
Photo by Wang-LysoLab (@WangLysolab)Photo by Wang-LysoLab (@WangLysolab)Photo by Wang-LysoLab (@WangLysolab)Photo by Wang-LysoLab (@WangLysolab)Photo by Wang-LysoLab (@WangLysolab)Photo by Wang-LysoLab (@WangLysolab)Photo by Wang-LysoLab (@WangLysolab)Photo by Wang-LysoLab (@WangLysolab)Photo by Wang-LysoLab (@WangLysolab)Photo by Wang-LysoLab (@WangLysolab)
(1/16) Seen people’s research timelines, so story time! (It’s well told by @elandhuis in this article: science.org/content/article/…) Also have @brianchandotcom and his family to thank for believing in me and putting me on track to where I am today. Cannot overstate my gratitude.
1
5
599
Wang-LysoLab retweeted
If the Generalized Riemann Hypothesis (the stronger version of the Riemann Hypothesis) is proven, these become proven facts: Algorithms that no longer need randomness - Primality testing: Miller's fast test becomes proven correct with no randomness - Square roots mod a prime: becomes solvable fast and with no coin flips (today that's an open problem) - Cube roots and other roots mod a prime: same. - Factoring polynomials over finite fields: almost fast (quasi-polynomial) with no randomness, instead of needing randomness - Building finite fields: you can construct any finite field directly, with no random search - Factoring vs. φ(n): factoring a number becomes provably as easy as computing φ(n), even without randomness - Primes with a given remainder: a prime with any allowed remainder mod q exists that's at most about q², so searching for one is fast Complexity theory - Polynomial equations: "does this system of equations have a solution?" drops from PSPACE to a much lower class (AM) - Algebraic P vs NP: Valiant's algebraic version of P vs NP gets tied to the normal P vs NP over the complex numbers - Turing machines: a known 744-state Turing machine is proven to run forever Number theory software - Math libraries: PARI/GP and Magma results computed "assuming GRH" become fully proven - Class groups: algorithms that compute these number-field structures get guaranteed running times - Elliptic curve generation: the algorithms used to create curves for crypto get guaranteed running times Cryptography (no new attacks, only proofs) - Elliptic curves: proven that if discrete log is hard on one curve, it's hard on almost all similar curves - Lattice crypto: known quantum attacks on some lattice schemes become proven to work - Isogeny crypto: known quantum attacks on some isogeny schemes get proven speeds - Code-based crypto: schemes like BIKE get the guarantee that the special primes they need exist Prime gaps - Next prime: there's always one within about √p·log p of p, so "find the next prime" has a guaranteed worst case What it does NOT do - It doesn't solve P vs NP - It doesn't make factoring easy, so RSA and elliptic-curve crypto stay safe - It doesn't make anything faster in practice, because randomized versions already work today - Ramanujan graphs, expanders and AG codes are unaffected: they use a finite-field version of RH that was proven decades ago
76
590
57
4,644
468,640
Is the Generalized Riemann Hypothesis (GRE) proven for certain?? If so, tremendous implications for prime number density and many theorems that assume GRE (like the Goldbach Conjecture) Totally math nerding out!!! scientificamerican.com/artic…
9
Wang-LysoLab retweeted
It’s all over but the shouting. In the span of a single day that will echo through mathematics history, the solution to math’s hardest problem was announced—and then independently verified. sciam.com/article/the-ai-rie…
115
623
113
3,131
278,807
Wang-LysoLab retweeted
A video from the Progeria Research Foundation describing SamPro-2, the adenine base editor that corrects the LMNA c.1824C>T mutation underlying >90% of progeria cases, developed by @liugroup, Francis Collins's team, and the Progeria Research Foundation. youtube.com/watch?v=pnRq195u…
5
21
3
95
11,778
Extremely disturbing and concerning news regarding #CRISPR #ABE (Adenine Base Editing) for human central nervous system disease science.org/content/article/… Though no safety signal in mice and NHP, a child with CHD3-associated disease received CNS gene editing and died
1
48
The details about what vector, the dosage, and immunosuppressive regimen the girl received are unknown. Not the first time a CNS-dosed AAV patient has died (clinicaltrialsarena.com/news…) This is the first time a #CRISPR dosed patient has died, without apparent animal safety signal
1
4
Very concerning and a reminder that any laboratory scientific success / publication must keep paramount the safety and welfare of the patients we do the research for!!
3
Wang-LysoLab retweeted
🧬Does this change the overall safety assessment of AAV gene therapy? After treating over 6,000 patients with AAV gene therapy without evidence of major long-term toxic effects, now the first published case of human oncogenesis linked to AAV integration has been documented: A 5-year-old boy with severe mucopolysaccharidosis type I (MPS I, Hurler syndrome) developed a neuroepithelial tumor four years after intracisternal magna administration of AAV9 gene therapy. 🔬 The molecular detective work is fascinating: Clonal integration of rearranged AAV vector elements into the PLAG1 gene, creating a chimeric AAV-PLAG1 transcript that drove tumor development. The integrated AAV DNA included duplicated enhancer-promoter sequences that upregulated PLAG1 expression 298-fold compared to other CNS tumors ✅ The tumor was successfully resected, and the patient maintains advanced cognitive function. ⚖️ Does this change the overall safety assessment? Not fundamentally, but it sharpens our focus. While AAV vectors predominantly persist as episomal concatemers, rare genomic integration has been known from neonatal murine models and liver biopsies in gene therapy patients. 👉 This case should translate into more stringent pharmacovigilance, with systematic long-term follow-up and tumor surveillance embedded into all AAV-based gene therapy programs. 🎯 Context is everything: The risk-benefit calculation varies dramatically by disease, vector design, dose, and delivery route. This case involved: - High vector concentrations (intracisternal magna delivery) - Ubiquitous promoter elements (necessary for lysosomal storage disease) - Possible host factors (prior HSCT) For conditions like haemophilia treated with lower systemic administration and liver-specific promoters, the profile differs markedly from CNS-directed therapy for MPS I, which requires ubiquitous promoters and high CNS transduction. #genetherapy #haemophilia @NEJM Rebecca Ahrens-Nicklas @DrSamelsonJones @LindseyAGeorge nejm.org/doi/full/10.1056/NE…
2
3
201
Wang-LysoLab retweeted
A staffing shortage is making it difficult for the US National Institutes of Health to spend its US$47-billion budget by awarding research grants. go.nature.com/4uG2mpm
13
2
25
9,688
Wang-LysoLab retweeted
Last week,Rob Henderson presented promising long-term safety & efficacy data from Tern Therapeutics clinical trial of TTX-381 gene therapy for ocular CLN2 Batten disease during the Association for Research in Vision & Ophthalmology (ARVO) 2026 conference. terntx.com/blog/Blog%20Post%…
1
1
88
#ASGCT2026: a fantastic meeting and only 2 days so far! • Watched @CLChristensen23 present her adenine base editing #CRISPR work with poise • Learned much re: safety measures for AAV geneTX • Forged hopeful new collabs • Caught up with good friends Thanks @ASGCTherapy!
6
Wang-LysoLab retweeted
Today in @ScienceTM, we report the use of in vivo adenine base editing to correct a variant causing Dravet syndrome, a severe childhood epilepsy and neurodevelopmental disorder, substantially ameliorating disease symptoms and extending lifespan in an animal model. 1/13 drive.google.com/file/d/12rc…
9
77
11
452
63,397
Our @MolTherapy publication is now in print! First-in-human dosing of RGX-111 gene therapy in a young Hurler syndrome boy with 2 affected brothers who died from SCT-related complications. Parents asked if gene therapy possible. sciencedirect.com/science/ar…
1
37
Not surprising to issue a Complete Response Letter (denial) given the hold. Disappointing for MPS therapeutics nonetheless. The clinical data includes neurocognitive testing in addition to D2S6 which, in the young kids, was very, very positive.
28
One of the many frustrating issues with rare disease therapeutics is moving goal posts. One administration's FDA encourages surrogate biomarker endpoints, the next declares them untenable. A serious problem getting treatments to patients !!
The FDA rejected Regenxbio’s Hunter syndrome gene therapy, taking issue with the surrogate biomarker the company used to apply for accelerated approval Its bad news not only for $RGNX but also Denali and Ultragenyx, who have used the same biomarker endpoints.news/fda-rejects-r…
1
1
8
1,234